Health Care

Do Institutional Investors Love Sangamo Biosciences Inc (NASDAQ:SGMO)?

Shares of NAVI have downtrended -10.25% in the past three months, while the S&P 500 has moved -15.53% in that time.

Since September 15, 2017, it had 0 buys, and 1 sale for $366,765 activity. (NYSE:V), 32 have Buy rating, 0 Sell and 7 Hold. It has underperformed by 48.30% the S&P500.

TRADEMARK VIOLATION NOTICE: "Insider Selling: Sangamo Therapeutics, Inc".

The average 1-year price target for Navient Corporation (NAVI) - averaging the work of different analysts - reveals a mean PT of $15.83/share. The Altrinsic Global Advisors Llc holds 580,000 shares with $5.10 million value, down from 630,000 last quarter. Jane Street Group LLC purchased a new position in shares of Sangamo Therapeutics in the third quarter worth about $624,000. The stock increased 2.58% or $0.42 during the last trading session, reaching $16.92. About 1.21 million shares traded.

Sangamo Therapeutics, Inc. has a 1-year low of $2.85 and a 1-year high of $18.40. It has outperformed by 13.08% the S&P500. Therefore 60% are positive. Zacks Investment Research upgraded shares of Sangamo Therapeutics from a "hold" rating to a "buy" rating and set a $12.00 price objective for the company in a report on Friday, August 18th. Piper Jaffray Companies raised shares of Sangamo Therapeutics from a "neutral" rating to an "overweight" rating and set a $19.00 price target on the stock in a research note on Wednesday, November 15th. The company was downgraded on Monday, May 16 by Compass Point. The stock of Visa Inc. RBC Capital Markets maintained the shares of V in report on Monday, August 21 with "Buy" rating. The rating was upgraded by ValuEngine to "Hold" on Thursday, May 25. The firm earned "Outperform" rating on Friday, December 4 by Wells Fargo.

KB Home operates as a homebuilding company in the United States. 2,630,075 shares of the company were exchanged, compared to its average volume of 1,323,054. The firm offers front-end services, including general agency services, specialty underwriting, and policyholder services to insurance carrier clients; produces and administers traditional and alternative market workersÂ' compensation insurance programs within risk classes and geographies specified by its insurance carrier clients; and provides reinsurance captive entity design and management services comprising formation and management of segregated portfolio cell captives. It also provides back-end services, such as claims administration services that are related to the administration and resolution of workersÂ' compensation claims, which are created to reduce costs for its clients; and various specialty services, such as healthcare cost containment, onsite investigations, loss control, transportation and translation, lien resolution, and legal bill review services.

Also included in the list of buyers for the last 3 months Curt A. Iii Herberts who executed a direct buy for 11,803 shares on December 4, 2017.Director Saira Ramasastry bought 5000 shares on November 17, 2017, bringing his total number of shares held to 5000. About 297,931 shares traded. Moreover, Alyeska Inv Group Limited Partnership has 0.01% invested in Sangamo Therapeutics, Inc.

A number of research analysts recently weighed in on SGMO shares.

About Sangamo Therapeutics Sangamo Therapeutics, Inc, formerly Sangamo BioSciences, Inc, is a clinical-stage biotechnology company. (NASDAQ:SGMO). Davenport Company Ltd Limited Liability Company owns 40,000 shares or 0% of their U.S. portfolio. The firm's revenue for the quarter was up 333.0% on a year-over-year basis. analysts anticipate that Sangamo Therapeutics, Inc. will post -0.73 earnings per share for the current fiscal year.

Investors sentiment increased to 1.81 in Q2 2017. Current market cap is $1.35B and the stock has an EPS of -$0.69. It is positive, as 13 investors sold SGMO shares while 31 reduced holdings. 43 funds opened positions while 75 raised stakes. On Wednesday, August 9 the insider HOLLINGER WILLIAM R sold $1.33 million.

For this year, Sangamo Therapeutics, Inc. Rhumbline Advisers holds 82,691 shares or 0% of its portfolio. (NASDAQ:SGMO) for 5,000 shares. Cubist Systematic Strategies Limited Liability Corp owns 0.01% invested in KB Home (NYSE:KBH) for 9,155 shares. Weiss Multi reported 0.03% of its portfolio in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) on Wednesday, September 20. (NASDAQ:SGMO) for 113,301 shares. Bnp Paribas Arbitrage has invested 0% in Sangamo Therapeutics, Inc.

The consensus recommendation - averaging the work of 7 analysts - of 1.9 for Sangamo Therapeutics, Inc. California Employees Retirement reported 0% stake. Wedbush reaffirmed a "neutral" rating and set a $4.00 price target (down from $6.00) on shares of Sangamo Therapeutics in a research report on Tuesday, May 16th. (NASDAQ:SGMO). Weiss Multi stated it has 75,000 shares. Point72 Asset Management L.P. now owns 693,300 shares of the biopharmaceutical company's stock valued at $10,400,000 after purchasing an additional 335,595 shares during the period. (NASDAQ:SGMO). Goldman Sachs Group Inc Inc has invested 0% of its portfolio in Sangamo Therapeutics, Inc. Rfg Advisory Grp Incorporated Lc has 0.06% invested in Visa Inc. Beach Invest Mgmt Ltd Liability Company accumulated 1.39% or 144,089 shares.



Like this

Latest


17 December 2017
US Bancorp (NYSE:USB) Shares Bought by Williams Jones & Associates LLC
About 62,989 shares traded or 36.20% up from the average. (NAUH) has risen 10.50% since December 16, 2016 and is uptrending. Bancorp ( USB ) Stock" was originally posted by TrueBlueTribune and is the property of of TrueBlueTribune.

17 December 2017
JetBlue Airways Corporation (NASDAQ:JBLU) VP Sells 1045 Shares of Stock
The stock of JetBlue Airways Corporation (NASDAQ: JBLU ) earned "Overweight" rating by Barclays Capital on Thursday, December 15. Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on February, 1. (NYSE:JPM) to report earnings on January, 12.

17 December 2017
Man left with serious injuries after officer-involved shooting in Newport News
Police said deputies from the Rockbridge County Sheriff's office shot a robbery suspect Friday after he pointed a handgun at them. A criminal and investigative investigation will take place, which is standard in any officer-involved shooting.

17 December 2017
9 more women accuse Russell Simmons of rape or sexual harassment
Although he has stepped down from his companies , including RUSH Communications, he strenuously denies any non-consensual sex. When she resisted, Sallie said he attacked her, grabbed her by the hair and tried to chase her into the women's bathroom.

17 December 2017
The Bristol-Myers Squibb Company Sees Unusually High Options Volume (NYSE:BMY)
Public Employees Retirement System of OH raised its position in shares of Bristol-Myers Squibb by 0.7% in the 3rd quarter. Following the transaction, the executive vice president now owns 584,373 shares in the company, valued at $37,031,717.01.

17 December 2017
Teacher-couple sacked on marriage day, reinstated after public outrage in Kashmir
Tariq Bhat and Sumaya Rashid were sacked by the school administration to which they have chose to challenge the decision. The couple dubbed the decision as injustice to them and they would fight it back.

17 December 2017
Is Nordson (NASDAQ:NDSN) In Trouble? Gabelli \u0026 Co. Issues Downgrade
Zacks Investment Research cut Nordson from a "hold" rating to a "sell" rating in a research report on Thursday, August 24th. With 211,900 avg volume, 7 days are for Nordson Corporation (NASDAQ: NDSN)'s short sellers to cover NDSN's short positions.

17 December 2017
BidaskClub Lowers Portola Pharmaceuticals (PTLA) to Strong Sell
Portola Pharmaceuticals has a 1 year low of $18.30 and a 1 year high of $67.10. 13,643 were reported by Airain. Geode Capital Mgmt Limited Liability Company invested 0.01% of its portfolio in Portola Pharmaceuticals, Inc.

17 December 2017
Anheuser Busch Inbev NV (BUD) Shares Bought by Moors & Cabot Inc
Illinois-based Hightower Advsr Limited Liability Corporation has invested 0.03% in Anheuser-Busch InBev SA/NV (NYSE:BUD). Campbell Communications Inv Adviser Llc invested 0.2% of its portfolio in Louisiana-Pacific Corporation (NYSE:LPX).

17 December 2017
BidaskClub Lowers TTM Technologies (NASDAQ:TTMI) to Hold
BidaskClub cut shares of TTM Technologies from a "hold" rating to a "sell" rating in a report on Monday. TTM Technologies, Inc. (NASDAQ: TTMI ) has risen 142.01% since December 15, 2016 and is uptrending.



Recommended